Akt1/PKBα (Full-Length) Protein, Active
Original price was: $2,195.00.$1,095.00Current price is: $1,095.00.
Catalog Number: B2023598 (15 ug)
Akt1/PKBα, is a serine/threonine kinase involved in cellular processes such as metabolism, cell proliferation, and growth. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.
Live enquiry about this product via Text/SMS: 1-858-900-3210.
In stock
Product Description
Akt1/PKBα (Full-Length) Protein, Active
Catalog number: B2023598
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 15 ug
Molecular Weight or Concentration: 59.9 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -70°C
Keywords: Protein kinase B alpha, Proto-oncogene c-Akt, RAC, RAC-PK-alpha
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1. Kohn, A. D., et al. (1996). “Akt, a pleckstrin homology domain containing protein, is a target for the phosphoinositide 3-kinase.” *Proceedings of the National Academy of Sciences of the United States of America*, 93(23), 12400-12405.
2. Alessi, D. R., et al. (1996). “Mechanism of activation of protein kinase B by insulin and IGF-1.” *The EMBO Journal*, 15(23), 6541-6551.
3. Franke, T. F., et al. (1997). “Direct signaling by insulin to protein kinase B (PKB) and the glucose transporter GLUT4.” *The Journal of Biological Chemistry*, 272(24), 14767-14770.
4. Toker, A., & Cantley, L. C. (1997). “Signaling through the lipid products of phosphoinositide 3-kinase.” *Nature*, 387(6634), 673-676.
5. Datta, S. R., et al. (1997). “Akt is a central mediator of cell survival and apoptosis.” *Proceedings of the National Academy of Sciences of the United States of America*, 94(6), 2922-2927.
6. Downward, J. (1998). “Mechanisms and consequences of activation of protein kinase B/Akt.” *Current Opinion in Cell Biology*, 10(2), 262-267.
7. Vivanco, I., & Sawyers, C. L. (2002). “The phosphatidylinositol 3-kinase AKT pathway in human cancer.” *Nature Reviews Cancer*, 2(7), 489-501.
8. Manning, B. D., & Cantley, L. C. (2007). “AKT/PKB signaling: navigating downstream.” *Cell*, 129(7), 1261-1274.
9. Gharbi, S. I., et al. (2007). “Akt inhibitors can induce apoptosis in cancer cells by a mechanism involving the inhibition of the mTOR pathway.” *Cancer Research*, 67(12), 5864-5872.
10. Goto, Y., et al. (2010). “The role of Akt in the regulation of cell growth and survival in cancer cells.” *Cancer Science*, 101(4), 823-829.
https://pubmed.ncbi.nlm.nih.gov/?term=Akt1/PKBα (Full-Length) Protein, Active
Products Related to Akt1/PKBα (Full-Length) Protein, Active can be found at Proteins
Additional Information
| Weight | 0.15 oz |
|---|---|
| Dimensions | 2 × 0.5 × 0.5 in |
Several ways to order Molecular Depot products:
1- Order online using our website’s automated shopping cart and checkout system (available 24/7).
2- Order by email: info@moleculardepot.com (we accept electronic PO, available 24/7).
3- Order by Live Chat.
4- Order by Fax: 1-858-437-9884 (available 24/7).







